Premium
Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an International Sjögren's syndrome registry
Author(s) -
Malladi Arundathi S.,
Sack Kenneth E.,
Shiboski Stephen C.,
Shiboski Caroline H.,
Baer Alan N.,
Banushree Ratukondla,
Dong Yi,
Helin Pekka,
Kirkham Bruce W.,
Li Mengtao,
Sugai Susumu,
Umehara Hisanori,
Vivino Frederick B.,
Vollenweider Cristina F.,
Zhang Wen,
Zhao Yan,
Greenspan John S.,
Daniels Troy E.,
Criswell Lindsey A.
Publication year - 2012
Publication title -
arthritis care and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.032
H-Index - 163
eISSN - 2151-4658
pISSN - 2151-464X
DOI - 10.1002/acr.21610
Subject(s) - medicine , sicca syndrome , primary biliary cirrhosis , systemic disease , dermatology , cohort , disease , gastroenterology
Abstract Objective To study the prevalence of extraglandular manifestations in primary Sjögren's syndrome (SS) among participants enrolled in the Sjögren's International Collaborative Clinical Alliance (SICCA) Registry. Methods A total of 1,927 participants in the SICCA registry were studied, including 886 participants who met the 2002 American–European Consensus Group (AECG) criteria for primary SS, 830 “intermediate” cases who had some objective findings of primary SS but did not meet AECG criteria, and 211 control individuals. We studied the prevalence of immunologic and hematologic laboratory abnormalities, specific rheumatologic examination findings, and physician‐confirmed thyroid, liver, and kidney disease, as well as lymphoma among SICCA participants. Results Laboratory abnormalities, including hematologic abnormalities, hypergammaglobulinemia, and hypocomplementemia, frequently occurred among primary SS cases and were more common among the intermediate cases than among control participants. Cutaneous vasculitis and lymphadenopathy were also more common among primary SS cases. In contrast, the frequency of physician‐confirmed diagnoses of thyroid, liver, and kidney disease and lymphoma was low and only primary biliary cirrhosis was associated with primary SS case status. Rheumatologic and neurologic symptoms were common among all SICCA participants, regardless of case status. Conclusion Data from the international SICCA registry support the systemic nature of primary SS, manifested primarily in terms of specific immunologic and hematologic abnormalities. The occurrence of other systemic disorders among this cohort is relatively uncommon. Previously reported associations may be more specific to select patient subgroups, such as those referred for evaluation of certain neurologic, rheumatologic, or other systemic manifestations.